Currently, more than 10 million people in Europe suffer from chronic wounds such as venous and pressure ulcers and an estimated 2–4% of European health care budgets is allocated for their care. According to National Health Service (NHS) in the UK, the estimated cost of wound care in 2012-2013 was about £5b. This figures will increase with demographic changes pointing to the rise in the population of elderly people (aged over 65). In the UK alone, the elderly population is predicted to increase from 9.5m (2005) to 13m (2025). Therefore, there is a need to develop advanced and efficient wound care products to ensure the health care system remain sustainable while attempting to improve better quality of life for the people.
Wound healing can be accelerated by using electrical stimulation. But, the current electrical stimulation technology is complex, non-portable, requires external power, and can only be used in hospitals. These issues along with the high-cost prohibit the use of existing method by the lay person and discourages self-health management. ELECTROHEAL aims to overcome these challenge and develop a simple, cost effective and disposable electroactive wound dressing or bandage to accelerate the wound healing process.
Two main objectives of ELECTROHEAL programme are to:
Obj1: Establish the suitability of piezoelectric amino acid crystals for wound healing.
Obj2: Develop a non-invasive method for wound healing based on a smart bandage covered by biocompatible glycine piezoelectric materials.